Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by Cristina Alomar-Dominguez et al., published in Thrombosis Research, adding:
“In clinical practice, FXIII deficiency is therefore often overlooked during acute bleeding due to the limited availability of rapid FXIII assays and the inability of routine tests and standard viscoelastic methods to reliably detect reduced FXIII activity.
As a consequence, FXIII substitution is either delayed until laboratory results become available or omitted altogether, particularly within mass transfusion protocols which typically prioritize fibrinogen and prothrombin complex concentrate (PCC).”
Title: Defining a fibrinogen-to-factor XIII replacement ratio in an in-vitro model of dilutional coagulopathy
Authors: Cristina Alomar-Dominguez, Marie Therese Bauer, Dietmar Fries, Ludwig Deinhart, Jennifer Gebetsberger, Mirjam Bachler, Johannes Bösch, Wolfgang Schobersberger, Martin Hermann, Christian Irsara, Luca Brunelli, Anna Katharina Tobiasch
Find more posts featuring Ana Pedrero Gil on Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda